Ligandi

Agonisti

Pozitivni alosterni modulatori

Antagonisti

Reference

1. ^Bridges TM; Marlo JE; Niswender CM; et al. (2009). „Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins”.J. Med. Chem.52 (11): 3445—8.PMID 19438238.doi:10.1021/jm900286j. CS1 одржавање: Експлицитна употреба et al. (веза)
2. ^Grant MK, El-Fakahany EE (2005). „Persistent binding and functional antagonism by xanomeline at the muscarinic M₅ receptor”.J. Pharmacol. Exp. Ther.315 (1): 313—9.PMID 16002459.doi:10.1124/jpet.105.090134. 

Literatura

• Brann MR; Ellis J; Jørgensen H; et al. (1994). „Muscarinic acetylcholine receptor subtypes: localization and structure/function.”.Prog. Brain Res.98: 121—7.PMID 8248499.doi:10.1016/S0079-6123(08)62388-2. CS1 одржавање: Експлицитна употреба et al. (веза)
• Gutkind JS, Novotny EA, Brann MR, Robbins KC (1991).„Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes.”.Proc. Natl. Acad. Sci. U.S.A.88 (11): 4703—7.PMC 51734 .PMID 1905013.doi:10.1073/pnas.88.11.4703. 
• Liao CF; Themmen AP; Joho R; et al. (1989). „Molecular cloning and expression of a fifth muscarinic acetylcholine receptor.”.J. Biol. Chem.264 (13): 7328—37.PMID 2540186. CS1 одржавање: Експлицитна употреба et al. (веза)
• Bonner TI, Young AC, Brann MR, Buckley NJ (1990). „Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes.”.Neuron.1 (5): 403—10.PMID 3272174.doi:10.1016/0896-6273(88)90190-0. 
• Crespo P; Xu N; Daniotti JL; et al. (1994). „Signaling through transforming G protein-coupled receptors in NIH 3T3 cells involves c-Raf activation. Evidence for a protein kinase C-independent pathway.”.J. Biol. Chem.269 (33): 21103—9.PMID 8063729. CS1 одржавање: Експлицитна употреба et al. (веза)
• Haga K; Kameyama K; Haga T; et al. (1996). „Phosphorylation of human m1 muscarinic acetylcholine receptors by G protein-coupled receptor kinase 2 and protein kinase C.”.J. Biol. Chem.271 (5): 2776—82.PMID 8576254.doi:10.1074/jbc.271.5.2776. CS1 одржавање: Експлицитна употреба et al. (веза)
• Kohn EC; Alessandro R; Probst J; et al. (1996). „Identification and molecular characterization of a m5 muscarinic receptor in A2058 human melanoma cells. Coupling to inhibition of adenylyl cyclase and stimulation of phospholipase A2.”.J. Biol. Chem.271 (29): 17476—84.PMID 8663391.doi:10.1074/jbc.271.29.17476. CS1 одржавање: Експлицитна употреба et al. (веза)
• Burstein ES, Spalding TA, Brann MR (1998). „The second intracellular loop of the m5 muscarinic receptor is the switch which enables G-protein coupling.”.J. Biol. Chem.273 (38): 24322—7.PMID 9733718.doi:10.1074/jbc.273.38.24322. 
• Sato KZ; Fujii T; Watanabe Y; et al. (1999). „Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines.”.Neurosci. Lett.266 (1): 17—20.PMID 10336173.doi:10.1016/S0304-3940(99)00259-1. CS1 одржавање: Експлицитна употреба et al. (веза)
• Wang H; Han H; Zhang L; et al. (2001). „Expression of multiple subtypes of muscarinic receptors and cellular distribution in the human heart.”.Mol. Pharmacol.59 (5): 1029—36.PMID 11306684. CS1 одржавање: Експлицитна употреба et al. (веза)
• Buchli R; Ndoye A; Arredondo J; et al. (2002). „Identification and characterization of muscarinic acetylcholine receptor subtypes expressed in human skin melanocytes.”.Mol. Cell. Biochem.228 (1–2): 57—72.PMID 11855742.doi:10.1023/A:1013368509855. CS1 одржавање: Експлицитна употреба et al. (веза)
• Strausberg RL; Feingold EA; Grouse LH; et al. (2003).„Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”.Proc. Natl. Acad. Sci. U.S.A.99 (26): 16899—903.PMC 139241 .PMID 12477932.doi:10.1073/pnas.242603899. CS1 одржавање: Експлицитна употреба et al. (веза)
• Fujii T, Watanabe Y, Inoue T, Kawashima K (2003). „Upregulation of mRNA encoding the M5 muscarinic acetylcholine receptor in human T- and B-lymphocytes during immunological responses”.Neurochem. Res.28 (3–4): 423—9.PMID 12675126.doi:10.1023/A:1022840416292. 
• Ota T; Suzuki Y; Nishikawa T; et al. (2004). „Complete sequencing and characterization of 21,243 full-length human cDNAs”.Nat. Genet.36 (1): 40—5.PMID 14702039.doi:10.1038/ng1285. CS1 одржавање: Експлицитна употреба et al. (веза)
• De Luca V; Wang H; Squassina A; et al. (2004). „Linkage of M5 muscarinic and alpha7-nicotinic receptor genes on 15q13 to schizophrenia”.Neuropsychobiology.50 (2): 124—7.PMID 15292665.doi:10.1159/000079102. CS1 одржавање: Експлицитна употреба et al. (веза)
• Qu J; Zhou X; Xie R; et al. (2006). „The presence of m1 to m5 receptors in human sclera: evidence of the sclera as a potential site of action for muscarinic receptor antagonists”.Curr. Eye Res.31 (7–8): 587—97.PMID 16877267.doi:10.1080/02713680600770609. CS1 одржавање: Експлицитна употреба et al. (веза)
• Anney RJ; Lotfi-Miri M; Olsson CA; et al. (2007).„Variation in the gene coding for the M5 muscarinic receptor (CHRM5) influences cigarette dose but is not associated with dependence to drugs of addiction: evidence from a prospective population based cohort study of young adults”.BMC Genet.8: 46.PMC 1978498 .PMID 17608938.doi:10.1186/1471-2156-8-46. CS1 одржавање: Експлицитна употреба et al. (веза)

Vidi još